Gene Biotherapeutics Inc.
PrivateLast Round
Series B
May 22, 2020
Est. Valuation
$20M
Total Funding Raised
$10.25M
Company Overview
Gene Biotherapeutics Inc. is a clinical-stage biotechnology company that develops and commercializes DNA-based biotherapeutics for the treatment of cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gene Biotherapeutics Inc. Comparables
Compare Gene Biotherapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XyloCor Therapeutics | 91% | |
| Renova Therapeutics | 81% | |
| AnGes, Inc. | 65% |
Gene Biotherapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 22, 2020 | ||||
| Series A | Jun 7, 2016 | ||||
| Strategic | Mar 3, 2014 | ||||
| Series A | Apr 4, 2013 | ||||
| Private Placement | Feb 16, 2012 | ||||
Private Placement | Oct 15, 2009 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2020
$1.7M round led by Nostrum Pharmaceuticals, LLC
- Jun 7, 2016
$3M round raised
Gene Biotherapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gene Biotherapeutics Inc.'s valuation, stock price, and market status.
Is Gene Biotherapeutics Inc. a public or private company?
Gene Biotherapeutics Inc. is a private company.
What is the current stock price of Gene Biotherapeutics Inc.?
Gene Biotherapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Gene Biotherapeutics Inc. worth (valuation)?
Valuation information for Gene Biotherapeutics Inc. is not publicly available.
Can I buy Gene Biotherapeutics Inc. stock?
Gene Biotherapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gene Biotherapeutics Inc.'s last funding round?
Gene Biotherapeutics Inc.'s most recent funding round was Private Placement on April 4, 2013.
Who are the main investors in Gene Biotherapeutics Inc.?
Investor information for Gene Biotherapeutics Inc. is not publicly disclosed.
Will Gene Biotherapeutics Inc. IPO soon?
No public IPO plans have been announced for Gene Biotherapeutics Inc..
How can I track Gene Biotherapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gene Biotherapeutics Inc.'s secondary market activity and sign up for updates.